Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 20,349 shares at $23.71 ($483K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Open-market sale of $483k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.71 | 10,067 | $239K | 49.5% |
| 2 | $23.71 | 10,067 | $239K | 49.5% |
| 3 | $24.50 | 215 | $5K | 1.1% |
| Total | $23.72 avg | 20,349 | $483K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |